Similarly, we hypothesize that that the global hypomethylation signature identified in SARC DICER1 and PIS DICER1 is result of a continuing process that persists throughout tumor progression/sarcomatous differentiation, rather than selection for a precursor cell with a pre-existing hypomethylated state. This evidence concerns the gene CDIPT and neoplasm.